Company / Cash & Equivalents
Omada Health, Inc. Cash & Equivalents History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$222.0M
FY2025
5-year range
$222.0M / $222.0M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#80 of 148
Health Care
What the data says
At $222M, Omada Health, Inc.'s cash & equivalents ranks #80 of 148 in the Health Care sector.
Based on SEC 10-K filings.
$222M in FY2025.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#80 of 148 in Health CareTop 54% of 148This company $222.0M Sector average $1.2B
▼
-81.1% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $222.0M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026